NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Korean Regulatory Post Marketing Surveillance for Somavert

CompletedN/A

Sponsor: Pfizer

Conditions: Acromegaly

Interventions: Somavert

Countries: South Korea

Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

All patients who have been prescribed as per local label and investigators' judgement under the setting of routine practice in Korea who are eligible.

Exclusion Criteria:

Patients who are contraindicated for Somavert

Locations (1)

Seoul, South Korea